EXEL

#690
Exelixis Inc
44.0600
-0.83%
부문:
베이스:
수익 통화:
일일 변동 비율
44.0600
44.0600
년간 변동
36.0000
47.2360
일일 변동
-0.83%
월간 변동
+1.26%
6달 변화
+12.86%
년간 변동율
+12.86%
이전 종가
44.4300
Open
44.0600
Bid
Ask
Low
44.0600
High
44.0600
양
359
Open full chart

Financials

Overview 성명 Statistics Dividends
Quarterly Annual
  • Market Capitalization 11.9652 B
  • Employee 1 077
  • Founded 1994
  • CEO Michael M. Morrissey
  • Website www.exelixis.com
  • Headquarter Delaware, United States
  • FIGI BBG000BQ4WF8
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
15.68
Price to sales ratio
5.29
Dividends per share
—
Dividend yield %
—

Exelixis Inc

Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration for medullary thyroid cancer with clinical activity in several other types of metastatic cancer.

뉴스